Diabetes and SARS-CoV-2 Infection: The Potential Role of Antidiabetic Therapy in the Evolution of COVID-19.

Pinchera BiagioNicola Schiano MorielloAntonio Riccardo BuonomoIsabella Di FilippoAnastasia TanzilloGiorgio BuzzoRiccardo VillariGentile Ivannull Federico Ii Covid Team

Published in: Microorganisms (2023)

Diabetes mellitus represents one of the most frequent comorbidities among patients with COVID-19, constituting a risk factor for a more severe prognosis than that of non-diabetic patients. However, the pathophysiological mechanism underlying this unfavorable outcome is still not completely clear. The goal of our study was to evaluate the potential role of antidiabetic therapy in the evolution of COVID-19.

Keyphrases

coronavirus disease
sars cov
type diabetes
respiratory syndrome coronavirus
cardiovascular disease
early onset
stem cells
risk assessment
adipose tissue
mesenchymal stem cells
drug induced